uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 12, 2013

FDA Warns Consumers About The Dangers Of DMAA

On April 11, 2013, the FDA warned consumers about the dangers of dietary supplements containing the ingredient 1,3-dimethylamylamine (DMAA).

Most commonly found in supplements for weight loss, muscle building and performance enhancement, DMAA can elevate blood pressure, which can lead to cardiovascular problems, including heart attack, shortness of breath and tightening of the chest. These effects may be increased when DMAA is taken with caffeine.

The FDA has received 86 reports of illness -including heart problems, nervous system and psychiatric disorders - and death associated with supplements containing this ingredient.

The agency has warned dietary supplement companies that products containing DMAA are illegal, and most have agreed to remove the ingredient from their formulas.

USPLabs, however, manufacturer of two products containing DMAA - Oxy Elite Pro and Jack3D - challenged the FDA's assertion that the ingredient was unsafe. The company submitted published studies to support their use of the ingredient, but FDA has reviewed these studies and found them to be insufficient.

Consumers are urged to check supplement labels, which may list DMAA as a variety of names, including 1,3-DMAA, 1,3-dimethylamylamine 1,3-dimethylpentylamine, 2-amino-4-methylhexane, 2-hexanamine,4-methyl-2-hexanamine, 4-methyl-2-hexylamine, 4-methyl- (9CI), dimethylamylamine, geranamine, methylhexanamine and methylhexanenamine. Some companies may also list DMAA as Pelargonium graveolens extract or geranium extract, as this plant was once thought to contain 1,3-dimethylpentylamine.

See's Reviews of Weight Loss Supplements, Muscle Enhancers, Arginine Supplements and Energy Drinks for tests of related products.

See Related Warnings:

DMAA Supplement Linked to Runner's Death

"Thermo Stimulating" Supplement Recalled -- Contained DMAA

USPLabs Settles Class Action Lawsuit Over Controversial DMAA Ingredient

Performance Enhancing Ingredient, DMAA, Not Really from Geraniums, Putting Its Use in Supplements in Doubt

FDA Warns USPLabs For Adulteration and Drug Claims

DMAA Supplements Pulled from Military Stores After 2 Deaths

Distribution of Weight Loss Product Containing DMAA Should Be Stopped Immediately, Warns FDA

To read the FDA's warning, use the link below.